Skip to content

PHARMIMPULSE

Active General partnershipfounded 2015active for 11 yearsRue de la Bachée 86, 1380 LasneKBO/BCE: BE 0634.979.024 subsidiary of PALATINE
Part of the group BLUESTONE 15 companies
See the group
PHARMIMPULSE
Financial year 2025
Follow ReportCompare

Annual accounts 2025

abbreviated format, filed on 27-09-2026, 58 days late
€171,172
▼ 79.7%
-€71,463
▼ €74,879
-€81,057
-€94,292
▼ €89,590
-70.5%
▼ 71.4 percentage points
0.50
▼ 0.49

The turnover shown is an estimate from the gross margin.

Turnover ≈ €440,000. Estimated: probably between €270,000 and €820,000.

Balance sheet

balance sheet total €109,700 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

-70.5%

Higher than 8% of 377 companies in 2025.

0.50

Higher than 9% of 367 companies in 2025.

-73.9%

Lower than 95% of 371 companies in 2025.

PHARMIMPULSE Middle half of the sector 80% of the sector Abbreviated accounts in employment activities (NACE 78)

Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: bottom quarter · Staff: middle half

Staff

€43,776

Staff costs divided by the average number of full-time equivalents.

-8 people

people who joined people who left

In 2025, 2 people joined and 10 left.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242022202120202019201820172016
Balance sheet: assets
20/58 109,700384,361219,964148,612172,674174,936162,852160,682201,121
21/28 16,9858,45311,00212,276-----
21 9,398--------
22/27 7,5878,45311,00212,276-----
24 408--------
26 7,1788,45311,00212,276-----
29/58 92,715375,908208,962136,335172,674174,936162,852160,682201,121
40/41 88,720360,040184,610113,499160,884159,379159,167119,537195,745
40 52,634306,286182,360111,249142,069157,129156,917117,287193,494
41 36,08653,7542,2502,25018,8152,2502,2502,2502,250
54/58 3,17515,05024,35222,83711,79015,5573,68441,1445,376
490/1 820818-------
Balance sheet: equity and liabilities
10/49 109,700384,361219,964148,612172,674174,936162,852160,682201,121
10/15 -77,3073,7503,7503,7503,7503,7503,7503,7503,750
10/11 3,7503,7503,7503,7503,7503,7503,7503,7503,750
100 -----3,7503,7503,7503,750
11 3,7503,750-------
1109/19 3,7503,750-------
14 -81,057--------
17/49 187,007380,611216,214144,862168,924171,186159,102156,932197,371
42/48 187,007380,611216,214143,062168,924171,186154,302155,732192,571
43 14,10422,819-------
430/8 14,10422,819-------
44 14,775153,83733,71431,34210,0818,83011,44113,564112,461
440/4 14,775153,83733,71431,34210,0818,83011,44113,564112,461
45 72,776117,153163,14391,175158,843132,921142,860142,16860,110
450/3 30,71438,29264,87729,11752,65939,37727,14033,94433,395
454/9 42,06278,86198,26662,058106,18493,544115,720108,22426,716
47/48 85,35286,80319,35720,545-29,435--20,000
492/3 ---1,800--4,8001,2004,800
Income statement
76A ---3,328-----
9900 171,172842,528715,651522,423659,211595,002718,392628,341395,048
62 240,771837,838712,975521,475659,157594,643718,404628,313393,559
630 1,4641,2751,275469-----
640/8 400-------200
9901 -71,4633,4161,40147954359-11281,289
75/76B 1,136468-1-232--
75 1,136468-1-232--
65/66B 2,8073,8841,4014805436021281,289
65 2,8073,8841,4014805436021281,289
9903 -73,133--------
67/77 7,924--------
9904 -81,057--------
9905 -81,057--------
Appropriation of the result
9906 -81,057--------
Social balance sheet
9087 5.512.613.511.213.213.614.213.38.8
Hours worked1013 6,30523,22522,48819,80220,84021,61324,69822,10515,344
Document PDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 16 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 27-09-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2025 annual accounts filed 58 days after the deadline. Filed on 27 September 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00532092.

Financial year Type Filed Reference Document
31-12-2025 abbreviated format 27-09-2026 2026-00532092 PDF
31-12-2024 micro format 21-10-2025 2025-00547464 PDF
31-12-2022 micro format 25-12-2023 2023-00538485 PDF
31-12-2021 full format 31-08-2022 2022-20404961 PDF
31-12-2020 full format 30-09-2021 2021-70100014 PDF
31-12-2019 full format 30-10-2020 2020-66100485 PDF
31-12-2018 full format 27-08-2019 2019-52800188 PDF
31-12-2017 full format 30-08-2018 2018-54500548 PDF
31-12-2016 full format 25-08-2017 2017-47700348 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242022202120202019201820172016
-69,9994,6912,676948-----
-79,593--------
9,997-012,745-----
-11,875-1,51511,047-3,76811,873-37,46035,768-
-94,292-4,703-7,252-6,7263,7503,7508,5504,9508,550
-70.5%1.0%1.7%2.5%2.2%2.1%2.3%2.3%1.9%
0.500.990.970.951.021.021.061.031.04
--57.6638.6345.0545.6542.4341.8552.63
-73.9%--------
-24.941.211.911.97-----

EBIT margin: not included in this filing.

Debt to equity is not shown because equity is negative. Debt divided by negative equity means nothing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item31-12-202531-12-202431-12-202231-12-2021
Employees at the balance-sheet date6141612
full-time513109
part-time1163
in full-time equivalents5.713.914.711.2
5.5-13.511.2
On a permanent contract6141310
Joined2-912
Left10-514

Source: social balance sheet in the 2021 to 2025 annual accounts

Investments

fixed assets acquired
Item2025202420222021
Tangible fixed assets€512--€12,745
Intangible fixed assets€9,485---
Financial fixed assets€0---
€1,464€1,275€1,275€469

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on PHARMIMPULSE

The operating result for 2025 is a loss of €71,463, after a profit of €3,416 in 2024. It is the lowest result since 2016.

Equity is negative. Debt (€187,007) exceeds the balance-sheet total (€109,700).

Large changes and their cause
  • 2025 Staff (FTE) -56% on 2024. The accounts now follow the abbreviated format, last year the micro format.

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure